Key result
Surgery for primary orbital liposarcoma is linked to ~90% recurrence without distant metastasis or death.
Why the study?
Liposarcomas are rare in the orbit, prompting an analysis to determine the clinical and pathological features unique to orbital cases.
Observational (n=10)
No
Primary orbital liposarcoma is a rare tumor that is highly prone to local recurrence and frequently misdiagnosed, though MRI can aid in preoperative identification.
High local recurrence after surgery warrants close surveillance in orbital liposarcoma; leaves open optimal multimodal strategies for this rare tumor.
PURPOSE: Liposarcomas are rare in the orbit. We analyzed a series of primary liposarcomas to determine the features unique to the orbit. METHODS: Records from 10 Chinese patients treated for primary orbital liposarcoma at Beijing Tongren Hospital, Capital Medical University, between September 2009 and September 2020 were reviewed. RESULTS: This cohort included four men and six women with age of onset ranging from 18 to 80 years. The pathology was myxoid liposarcoma in five patients, dedifferentiated liposarcoma in two patients, well-differentiated liposarcoma and pleomorphic liposarcoma in one patient each, and dedifferentiated liposarcoma and well-differentiated liposarcoma co-existing in one case. Magnetic resonance imaging (MRI) revealed a well-defined, irregular, or lobulated mass in the orbit, which contained components that were suppressible in the fat-suppression sequence, as well as components that were enhanced by gadolinium enhancement. Nine patients relapsed after surgery, with a mean recurrence of 2.44, and one patient was lost to follow-up. The interval between treatment and first recurrence ranged from 4 months to 16 years; 55.6% of patients with orbital liposarcoma relapsed within one year. Three patients underwent local excision alone, four patients underwent excision combined with radiotherapy, and three patients underwent exenteration. Half of the patients were misdiagnosed in the pathologic diagnosis after their first or multiple surgeries. No distant metastasis, death from tumors, or invasion of adjacent organs was observed after 21-150 months of follow-up. CONCLUSION: Orbital liposarcoma is easily misdiagnosed and prone to recurrence; however, MRI findings may help identify orbital liposarcoma prior to surgery. The optimal treatment choice remains to be discussed.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2023) conducted an observational in Primary orbital liposarcoma (n=10). Primary orbital liposarcoma was evaluated on Recurrence. In a cohort of 10 patients with primary orbital liposarcoma, 9 experienced recurrence after surgery, with 55.6% relapsing within one year, though no distant metastasis or death occurred.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: